BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18499417)

  • 1. Preface: Congress on Alternative Test Methods in Inhalation Toxicology.
    Hensel A
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):99. PubMed ID: 18499417
    [No Abstract]   [Full Text] [Related]  

  • 2. Foreword: Congress on Alternative Test Methods in Inhalation Toxicology.
    Vogel R
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):97. PubMed ID: 18395433
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternative test methods in inhalation toxicology: challenges and opportunities.
    Costa DL
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings of the Congress on Alternative Test Methods in Inhalation Toxicology. May 7-9, 2007. Berlin, Germany.
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):97-233. PubMed ID: 18798348
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment).
    Spielmann H; Grune B; Liebsch M; Seiler A; Vogel R
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):225-33. PubMed ID: 18440212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute toxicity testing of chemicals-Opportunities to avoid redundant testing and use alternative approaches.
    Creton S; Dewhurst IC; Earl LK; Gehen SC; Guest RL; Hotchkiss JA; Indans I; Woolhiser MR; Billington R
    Crit Rev Toxicol; 2010 Jan; 40(1):50-83. PubMed ID: 20144136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The patchwork of toxicological research for pharmaceutical testing.
    von Aulock S
    ALTEX; 2010; 27(1):1. PubMed ID: 20397314
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhalation toxicity studies: OECD guidelines in relation to REACH and scientific developments.
    Arts JH; Muijser H; Jonker D; van de Sandt JJ; Bos PM; Feron VJ
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):125-33. PubMed ID: 18455380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of reproductive and developmental toxicology under REACH.
    Scialli AR
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Available data on naphthalene exposures: strengths and limitations.
    Price PS; Jayjock MA
    Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S15-21. PubMed ID: 18078699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open letter to the German Chancellor Dr. Angela Merkel. Council Directive on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes.
    Simons KW
    ALTEX; 2010; 27(1):70-3. PubMed ID: 20397315
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro models of inhalation toxicity and disease. The report of a FRAME workshop.
    BéruBé K; Aufderheide M; Breheny D; Clothier R; Combes R; Duffin R; Forbes B; Gaça M; Gray A; Hall I; Kelly M; Lethem M; Liebsch M; Merolla L; Morin JP; Seagrave J; Swartz MA; Tetley TD; Umachandran M
    Altern Lab Anim; 2009 Feb; 37(1):89-141. PubMed ID: 19292579
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated decision-tree testing strategies for skin corrosion and irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():65-74. PubMed ID: 19025332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation toxicology: methodological and regulatory challenges.
    Pauluhn J
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):111-24. PubMed ID: 18468874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some reflections on the Fourth World Congress on Alternatives and Animal Use in the Life Sciences, New Orleans, Louisiana, August 11 through 15, 2002.
    Balls M; Combes R; Clothier R; Festing M; Halder M; Jukes N; Morton D
    J Appl Anim Welf Sci; 2003; 6(2):131-49. PubMed ID: 12909528
    [No Abstract]   [Full Text] [Related]  

  • 16. The reduction of the use of challenge testing to provide evidence of efficacy in tests of immunological veterinary medicinal products (IVMPs).
    Webster CJ
    Dev Biol Stand; 1996; 86():103-9. PubMed ID: 8785938
    [No Abstract]   [Full Text] [Related]  

  • 17. Implementation of three Rs alternatives in regulatory testing: possibilities and obstacles--the view of the validator.
    Halder M; Balls M
    Dev Biol (Basel); 2002; 111():199-206. PubMed ID: 12678242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the product equivalence of monoclonal antibodies for therapeutic and in vivo diagnostic human use in case of change from ascitic to in vitro production.
    Schäffner G; Haase M; Giess S
    Dev Biol Stand; 1996; 86():319-20. PubMed ID: 8785963
    [No Abstract]   [Full Text] [Related]  

  • 19. The EU REACH system: blessing in disguise or wolf in wolf's clothing?
    Bhogal N
    Altern Lab Anim; 2005 Apr; 33(2):81-2. PubMed ID: 16180983
    [No Abstract]   [Full Text] [Related]  

  • 20. Is the fish embryo toxicity test (FET) with the zebrafish (Danio rerio) a potential alternative for the fish acute toxicity test?
    Lammer E; Carr GJ; Wendler K; Rawlings JM; Belanger SE; Braunbeck T
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Mar; 149(2):196-209. PubMed ID: 19095081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.